Hiroaki Saito

Dr. Hiroaki Saito


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
HSHiroaki Saito
Hiroaki Saito
RIRyo Iwai
Ryo Iwai
TUTaketo Uchiyama
Taketo Uchiyama
MMMuneharu Miyake
Muneharu Miyake
SMShinichi Miyairi
Shinichi Miyairi
Cinchona alkaloids are effective additives for enantioselective O–H insertion of α-phenyldiazoacetate and water by rhodium(II) complexes. Addition of silica gel promotes O–H insertion in the reaction rate and the reaction proceeds smoothly at less than the freezing point of water, e.g., −10 °C, and provided mandelate in up to 50% ee. The results reported here are the highest asymmetric inductions obtained to date for O–H insertions via a Rh-carbenoid.

27 November 2019 in Molecules
Verified
Journal Article
Open access
PDF file
SMShota Machida
Shota Machida
SMSaki Mukai
Saki Mukai
RKRina Kono
Rina Kono
MFMegumi Funato
Megumi Funato
HSHiroaki Saito
Hiroaki Saito
TUTaketo Uchiyama
Taketo Uchiyama
Twenty-one natural and unnatural phenolic compounds containing a carbohydrate moiety were synthesized and their structure–activity relationship (SAR) was evaluated for α-glucosidase inhibition and antioxidative activity. Varying the position of the galloyl unit on the 1,5-anhydro-d-glucitol (1,5-AG) core resulted in changes in the α-glucosidase inhibitory activity and notably, particularly strong activity was demonstrated when the galloyl unit was present at the C-2 position. Furthermore, increasing the number of the galloyl units significantly affected the α-glucosidase inhibition, and 2,3,4,6-tetra-galloyl-1,5-AG (54) and 2,3,4,6-tetra-galloyl-d -glucopyranose (61) exhibited excellent activities, which were more than 13-fold higher than the α-glucosidase inhibitory activity of acertannin (37). Moreover, a comparative structure-activity study suggested that a hemiacetal hydroxyl functionality in the carbohydrate core and a biaryl bond of the 4,6-O-hexahydroxydiphenoyl (HHDP) group, which are components of ellagitannins including tellimagrandin I, are not necessary for the α-glucosidase inhibitory activity. Lastly, the antioxidant activity increased proportionally with the number of galloyl units.

1 January 2011 in HETEROCYCLES
Verified
Journal Article
Closed access
TTTohru Takabatake
Tohru Takabatake
STSaeka Takeuchi
Saeka Takeuchi
HSHiroaki Saito
Hiroaki Saito
SMShinichi Miyairi
Shinichi Miyairi

1 April 2019 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
HSHideyuki Shinohara
Hideyuki Shinohara
HSHiroaki Saito
Hiroaki Saito
TUTaketo Uchiyama
Taketo Uchiyama
MMMuneharu Miyake
Muneharu Miyake
SMShinichi Miyairi
Shinichi Miyairi
In order to develop an efficient organocatalyst for the enantioselective N–H insertion reaction via carbene/carbenoid, the catalytic core of the cinchona alkaloids was investigated. According to our working hypothesis of an eight-membered ring transition state in the N–H insertion reaction, two pairs of enantiomers related to 2-amino-1-phenylethanol were investigated for their chiral inducing potential. Since both (1R,2S)-isomers gave the N-phenyl-1-phenylglycine derivative enriched in the R-form, while their enantiomers gave the S-form, the 2-amino-1-phenylethanol structure is concluded to be the catalytic core of the cinchona alkaloid in the enantioselective N–H insertion reaction via rhodium(II) carbenoid.

1 January 2011 in HETEROCYCLES
Verified
Journal Article
Closed access
TTTohru Takabatake
Tohru Takabatake
AMAkira Mori
Akira Mori
YMYoshiteru Mikami
Yoshiteru Mikami
HSHiroaki Saito
Hiroaki Saito
KKKoji Kobayashi
Koji Kobayashi
HOHisashi Ohshima
Hisashi Ohshima

28 November 2025 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NONaoki Oikawa
Naoki Oikawa
NINatsu Inoue
Natsu Inoue
SIShogo Ishii
Shogo Ishii
TGTakumi Goto
Takumi Goto
HSHiroaki Saito
Hiroaki Saito
TUTaketo Uchiyama
Taketo Uchiyama
Background/Objectives: Linezolid is a first-in-class oxazolidinone antibiotic that exhibits activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. However, its clinical use is often restricted because of hematological toxicities, particularly thrombocytopenia, in patients with renal impairment. That side effect is thought to result from the systemic accumulation of pharmacologically inactive metabolites generated by oxidative degradation and ring-opening of the morpholine, but the details remain unclear. In this study, we established a novel synthetic route for four linezolid metabolites (PNU-142618, 142300, 142586 and 173558). Methods: The four major metabolites, which are secondary or tertiary amines, were synthesized using the aniline derivatives protected with a 2-nitrobenzensulfonyl (Ns) group. Results: Application of this Ns strategy enabled selective N-alkylation, enabling efficient synthesis of the target metabolites. The desired metabolites containing a carboxylic acid group were obtained as their sodium salts. This is the first report on the synthesis of PNU-142618 and 173558. Conclusions: The established synthetic pathway provides access to four linezolid metabolites. The results facilitated the provision of compounds necessary for comprehensive pharmacokinetic and toxicological studies.